Galecto adopts executive Separation Benefits Plan with tiered severance for C-Level officers

Damora Therapeutics, Inc.

Plan covers CEO, CFO, COO, CMO, General Counsel and other designated employees.
Non-Sale termination: CEO receives 15 months base salary; other C-Level get 12 months; prorated bonus and equity vesting during severance period.
Sale Event termination: CEO gets 18 months lump sum; other C-Level get 12 months lump sum; bonus of 150%/100% of target; 100% equity vesting.
Plan supersedes all prior severance agreements and requires a release of claims, non-disparagement, and cooperation as conditions.
Board may amend or terminate plan with 18 months' notice before a Sale Event; post-Sale Event amendments restricted for 24 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.